Form 4 · Filed Jul 6, 2026, 09:01 PM UTC
IMVT/Immunovant, Inc.
Venker Eric — President & Immunovant CEO
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
4 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 2, 2026 | S | sell | 3,092 | $38 | $118,980 | 254,280 |
| Jul 1, 2026 | M | other | 92,188 | $14 | $1,333,038 | 344,001 |
| Jul 1, 2026 | D | other | 86,629 | $38 | $3,304,030 | 257,372 |
| Jul 1, 2026 | M | other | 92,188 | — | — | 1,014,062 |
Source: SEC EDGAR raw filing ↗ · Accession 0001764013-26-000077